Defining sepsis in 2016: clarity or confusion
|
|
- Berenice Spencer
- 7 years ago
- Views:
Transcription
1 Defining sepsis in 2016: clarity or confusion Christopher W. Seymour, MD MSc The CRISMA Center Assistant Professor of Critical Care Medicine & Emergency Medicine University of Pittsburgh School of Medicine Can an otherwise healthy 58-year-old man die from a bad cold? He can, and he did. Through an unfortunate cascade of events, starting with a missed diagnosis of viral pneumonia, Tom Wilson, a systems analyst for Westinghouse, went from bad to worse until every major organ system -- kidneys, liver, lungs and finally his heart -- stopped working. After 10 days in intensive care during which doctors struggled in vain to get ahead of the rampaging disorder, Mr. Wilson died. Cause of death: septic shock. New York Times, March 5,
2 Minor illness Healthy guy Delay in the diagnosis of septic shock Absence of specific tests Rampaging disorder with organ dysfunction Why is defining sepsis important? Why is defining sepsis difficult? Conceptual approach by the 2016 Sepsis Definitions Task Force Review of Sepsis-3 Controversies post-release Objectives 2
3 Sepsis is everywhere. 2 5 million US cases each year percent of US healthcare spending Gaieski et al. Crit Care Med, 2014 Singer et al., JAMA, 2016 Sepsis is everywhere. 1 out of every 2 to 3 hospital deaths Liu et al., JAMA,
4 We don t talk about it. Stroke Heart attack Sepsis 12% 10% 20% Seymour et al., Am J Resp Crit Care Med, 2014 Why is defining sepsis difficult? Sepsis is common We don t agree on the terms Surface phenomena lead to small zone of rarity with lots of patients Time-sensitive diagnosis Knowledge is rapidly evolving Angus et al., Crit Care Med,
5 2016 Sepsis Definitions Task Force To re-examine existing criteria for sepsis and septic shock Does current pathophysiology, epidemiology mandate an update? Use expert consensus to develop a definition Use data to develop clinical criteria Focus is on the bedside clinician 5
6 Current state prior to Sepsis-3 Variety of terms Septicaemia, septic, severe sepsis, septic shock, sepsis 2 or more SIRS criteria to identify sepsis among those with suspected infection Organ dysfunction is key, but uncertain how to measure Multiple criteria for septic shock Shankar-Hari et al., JAMA, 2016 Infection Organ dysfunction Life threatening Dysregulated host response Singer et al., JAMA,
7 We have a definition for sepsis. Criteria for the bedside Criteria for Infection? Clinical diagnosis Not the prevue of the Task Force Criteria for organ dysfunction? Seymour et al., JAMA,
8 Developing sepsis criteria Use large electronic health record databases Identify those with suspected infection Study various existing OD criteria SOFA score LODS score SIRS criteria Levy et al., Crit Care Med, 2003 Use of predictive validity No gold standard for sepsis We can t rely on tests like sensitivity, specificity etc Use outcome more common in septic patients than healthy patients Outcome Septic Not septic 8
9 Candidate clinical criteria Primary cohort 9
10 Patient characteristics CRISMA conducted primary analyses on UPMC data Suspected infection patients 12 hospitals 4% mortality rate Patient characteristics 10
11 Variable Threshold Units All patients (N=74,453) ICU patients (N=7,836) Non-ICU patients (N=66,617) Heart rate >90 BPM Respiratory rate >20 BPM SIRS variables Temperature <36 C White blood cell count >12 k/ul Temperature >38 C White blood cell count <4 k/ul Bands >10 % Systolic blood pressure <=100 mmhg Serum creatinine >=1.2 mg/dl Pa0 2 / Fi0 2 ratio <=300 SOFA variables Platelets <=150 k/ul Glasgow coma scale <15 Bilirubin >=1.2 mg/dl Mechanical ventilation Present/absent Vasopressors Present/absent Vasopressors More than one Bicarbonate <=26 mmol/l Saturation <=94 % Glucose <=109 mg/dl AST >=36 IU/L Additional candidate variables ALT >=37 IU/L INR >=1.4 Albumin <=2.5 g/dl Troponin >=0.1 ng/ml ph <=7.36 Lactate >=2.5 mmol/l Fibrinogen <=300 mg/dl ScvO 2 <=69 % Abnormal Normal Missing Proportion (%) Proportion (%) Proportion (%) What do we already know at the bedside We built a baseline risk model using only age, demographics, race, co-morbidity Divide patients into deciles No. of patients Risk of in-hospital mortality 7,449 7,456 7,515 7,372 7,572 7,301 7,523 7,390 7,515 7,346 Deciles of baseline risk of in-hospital mortality Compare validity within and across deciles 11
12 Predictive validity of criteria Fold change, in-hospital mortality Baseline risk (%) ICU encounters N = 7,932 SIRS 2 vs. SIRS <2 SOFA 2 vs. SOFA <2 LODS 2 vs. LODS <2 qsofa 2 vs. qsofa < Decile of baseline risk of in-hospital mortality Predictive validity of criteria Baseline risk (%) Fold change, in-hospital mortality Outside the ICU encounters N = 66,522 SIRS 2 vs. SIRS <2 SOFA 2 vs. SOFA <2 LODS 2 vs. LODS <2 qsofa 2 vs. qsofa < Decile of baseline risk of in-hospital mortality 12
13 But SOFA is complex Sepsis criteria should be easy SOFA is complex, requires 12 variables, costly, range from 0 to 24 points Laboratory tests take time to result We need more simple parsimonious criteria for the bedside quick Sepsis - Related Organ Failure Assessment 13
14 qsofa as a clinical prompt 3 variables Measured near onset of infection No laboratory tests Studied in 72 6 hr windows around infection qsofa as a clinical prompt SIRS 0.64 (0.62, 0.66) ICU encounters N = 7,932 AUROC in-hospital mortality SIRS 0.76 (0.75, 0.77) Outside the ICU encounters N = 66,522 AUROC in-hospital mortality SOFA < (0.73, 0.76) SOFA < (0.78, 0.80) LODS < (0.73, 0.76) LODS <0.01 < (0.80, 0.82) qsofa 0.01 <0.01 < (0.64, 0.68) qsofa <0.01 < (0.80, 0.82) SOFA and LODS superior in the ICU qsofa similar to complex scores outside the ICU 14
15 qsofa in external datasets 15
16 Serum lactate as an adjunct Proportion in hospital mortality (%) Missing qsofa = 0 qsofa = 1 qsofa = 2 qsofa = 3 < 2.0 mmol/l 2.0 to 4.0 mmol/l Serum lactate 4.0 mmol/l Fold change, in-hospital mortality Baseline risk (%) Median Minimum Maximum qsofa 2 vs. qsofa <2 (qsofa + serum lactate) 2 vs. (qsofa + lactate) < Decile of baseline risk for in-hospital mortality Addressed missing data Post hoc analyses Measurement windows for qsofa and SOFA 24 hrs after infection 6 hr window around infection Agreement of SOFA and qsofa exceeded 70% Delta of 2 SOFA points same predictive validity 16
17 Conclusions In the ICU, the SOFA and LODS have greater predictive validity than qsofa or SIRS Outside the ICU, the qsofa has similar predictive validity to more complex scores Clinical criteria for sepsis Infection plus 2 or more SOFA points above baseline Prompt to consider sepsis outside the ICU Infection plus 2 or more qsofa points 17
18 Controversies Where did severe sepsis go? Billing implications Was SIRS just left for dead? Delays in treatment if infection not suspected Why isn t lactate in the criteria? Lacks face validity to not include Prospective evaluation? No association of new definitions with better outcomes Controversies Change in SOFA from what baseline value? Practical implementation is challenging Measure altered mentation? Multiple different scales available What to do if intermediate risk? qsofa = 1 Isn t the AUROC a bad measure of clinical usefulness? 18
19 Why Sepsis-3 provides clarity Speak the same language Redundant terms like severe sepsis are removed Objective criteria for organ dysfunction recommended Data driven Why Sepsis-3 may lead to confusion Other criteria are available CMS, CDC surveillance criteria, RCT inclusion criteria Unclear how to chose time windows to measure criteria Blessing and curse of EHR data Suspected infection is a clinical decision No check boxes proposed by Task Force 19
20 My approach outside the ICU My approach outside the ICU Pt arrives to ED This looks like pneumonia! Frequent reassessment Did qsofa already occur? Send lactate and SOFA labs 3 6 hr look back Sepsis 20
21 My approach inside the ICU Resources
22 Questions 22
Sepsis: Identification and Treatment
Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge
More informationThe Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting
More informationDecreasing Sepsis Mortality at the University of Colorado Hospital
Decreasing Sepsis Mortality at the University of Colorado Hospital Maureen Dzialo, RN, BSN - Nurse Manager, Cardiac Intensive Care Unit Olivia Kerveillant, RN Clinical Nurse III, Medical Intensive Care
More informationSE5h, Sepsis Education.pdf. Surviving Sepsis
Surviving Sepsis 1 Scope and Impact of the Problem: Severe sepsis is a major healthcare problem that affects millions of people around the world each year with an extremely high mortality rate of 30 to
More informationBUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN
BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN R. Phillip Dellinger MD, MSc, MCCM Professor of Medicine Cooper Medical School of Rowan University Professor of Medicine University Medicine and Dentistry of
More informationUsing Predictive Analytics to Improve Sepsis Outcomes 4/23/2014
Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014 Ryan Arnold, MD Department of Emergency Medicine and Value Institute Christiana Care Health System, Newark, DE Susan Niemeier, RN Chief Nursing
More informationSubject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013
Stony Brook Medicine Severe Sepsis/Septic Shock Recognition and Treatment Protocols Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August
More informationCore Measures SEPSIS UPDATES
Patricia Walker, RN-BC, BSN Evidence Based Practice Manager Quality Management Services UCLA Health System, Ronald Reagan Medical Center Core Measures SEPSIS UPDATES Sepsis Core Measures Bundle Requirements
More informationRuchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center
Modified Early Warning Score (MEWS) Ruchika D. Husa, MD, MS Assistant t Professor of Medicine i in the Division of Cardiology The Ohio State University Wexner Medical Center MEWS Simple physiological scoring
More informationUnderstanding Lactate in an Intensive Care Setting. Hilary G. Mulholland
Understanding Lactate in an Intensive Care Setting by Hilary G. Mulholland S.B., Massachusetts Institute of Technology (2014) Submitted to the Department of Electrical Engineering and Computer Science
More informationSepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status
Patient exhibits two or more of the following SIRS criteria: Temperature greater than 38 o C (100.4 o F) or less SIRS than criteria 36 o C (96.8 o F) Heart Rate greater than 90 beats/minute Respiratory
More informationTelemedicine Resuscitation & Arrest Trials (TreAT)
Telemedicine Resuscitation & Arrest Trials (TreAT) Telemedicine within the ED for treating Severe Sepsis: A Hub and Spoke Telemedicine pilot SUMR Intern: Karole Collier Mentor: Dr. Brendan Carr & Dr. Anish
More informationLynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures
Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor No disclosures 1 2 3 Discuss data requirements -3 hour bundle -6 hour bundle Challenges and compliance issues Success 4 Based on the Surviving Sepsis
More informationInpatient Code Sepsis March Update. Sarah Prebil
Inpatient Code Sepsis March Update Sarah Prebil 3 hour bundle Time is life Kumar et al. Crit Care Med 2006; 34:1589-1596 But Sarah, why are you harassing us about sepsis? Pilot Results 10 Code Sepsis pabents
More informationAcid-Base Balance and the Anion Gap
Acid-Base Balance and the Anion Gap 1. The body strives for electrical neutrality. a. Cations = Anions b. One of the cations is very special, H +, and its concentration is monitored and regulated very
More informationCLINICAL DECISION-SUPPORT SYSTEMS (ALERTS), WHAT ARE THEY AND CAN THEY HELP MY PATIENT?
CLINICAL DECISION-SUPPORT SYSTEMS (ALERTS), WHAT ARE THEY AND CAN THEY HELP MY PATIENT? Robert Sherwin, MD Assistant Professor of Emergency Medicine Wayne State University School of Medicine Sinai Grace
More informationAcute on Chronic Liver Failure: Current Concepts. Disclosures
Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationThe Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
More informationJohn Gasman, MD Alec Jamieson, RN, MSN Kim Clifforth, RN, BSN, MSN, CNS Thomas T. Lam, MD. June 18, 2013
John Gasman, MD Alec Jamieson, RN, MSN Kim Clifforth, RN, BSN, MSN, CNS Thomas T. Lam, MD June 18, 2013 Objectives Acquire knowledge on defining sepsis, severe sepsis and septic shock Recognize SIRS criteria.
More informationAdam J. Singer, MD, Merry Taylor, RN, Anna Domingo, Saad Ghazipura, Adam Khorasonchi, Henry C. Thode, Jr., PhD, and Nathan I.
ORIGINAL CONTRIBUTION Diagnostic Characteristics of a Clinical Screening Tool in Combination With Measuring Bedside Lactate Level in Emergency Department Patients With Suspected Sepsis Adam J. Singer,
More informationCase Study: Using Predictive Analytics to Reduce Sepsis Mortality
Case Study: Using Predictive Analytics to Reduce Sepsis Mortality 1 Learning Objectives 1. Understand how an automated, real time IT intervention can help care teams recognize and intervene on critical,
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationANTIBIOTICS IN SEPSIS
ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics
More informationCreating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data
Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data Michael Pine, M.D., M.B.A. Michael Pine and Associates, Inc. mpine@consultmpa.com Overview
More informationHepatitis C. Laboratory Tests and Hepatitis C
Hepatitis C Laboratory Tests and Hepatitis C If you have hepatitis C, your doctor will use laboratory tests to check your health. This handout will help you understand what the major tests are and what
More informationMortality Assessment Technology: A New Tool for Life Insurance Underwriting
Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity
More informationOptimal fluid therapy in 2013. Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University
Optimal fluid therapy in 2013 Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University EGDT: fluids are good & prevent AKI Lin et al, Shock 2006 EGDT and AKI Prowle et
More informationOMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!
How to Interpret and Use Them René Romero, M.D. Clinical Director, Pediatric Hepatology CPG Gastroenterology, Hepatology and Nutrition Emory University School of Medicine Objectives Understand the anatomy
More informationVASOPRESSOR AGENTS IN SEPTIC SHOCK
VASOPRESSOR AGENTS IN SEPTIC SHOCK Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles President European Society of Intensive
More informationApproach to Abnormal Liver Tests
Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School
More informationWhy and how to have end-of-life discussions with your patients:
Why and how to have end-of-life discussions with your patients: A guide with a suggested script and some basic questions to use The medical literature consistently shows that physicians can enhance end-of-life
More informationSEVERE SEPSIS/SEPTIC SHOCK. Erica C. DeBoer BSN, MA,CCRN-K, CNL
SEVERE SEPSIS/SEPTIC SHOCK Erica C. DeBoer BSN, MA,CCRN-K, CNL OBJECTIVES Define severe sepsis and septic shock List core measure/early management steps for severe sepsis and septic shock Describe implementation
More informationData Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota
Data Management Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota None Disclosures Objectives History of data management in medicine Review of data management
More informationSeptic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident
Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor
More informationElectronic health records: underused in the ICU?
Electronic health records: underused in the ICU? Christopher W. Seymour, MD MSc Assistant Professor of Critical Care Medicine Core Faculty Member, CRISMA Center University of Pittsburgh School of Medicine
More informationPremature Infant Care
Premature Infant Care Introduction A premature baby is born before the 37th week of pregnancy. Premature babies are also called preemies. Premature babies may have health problems because their organs
More informationAcute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.
The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal
More information*6816* 6816 CONSENT FOR DECEASED KIDNEY DONOR ORGAN OPTIONS
The shortage of kidney donors and the ever-increasing waiting list has prompted the transplant community to look at different types of organ donors to meet the needs of our patients on the waiting list.
More informationAlbumin and All-Cause Mortality Risk in Insurance Applicants
Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH
More informationBenjamin M. Marlin Department of Computer Science University of Massachusetts Amherst marlin@cs.umass.edu January 21, 2011
Modeling and Prediction With ICU Electronic Health Records Data Department of Computer Science University of Massachusetts Amherst marlin@cs.umass.edu January 21, 2011 The Big Picture: History of Medical
More informationSt Lucia Diabetes and Hypertension Screening and Disease Management Programs
St Lucia Diabetes and Hypertension Screening and Disease Management Programs Michael Graven, MD, MSc,, MPH, FAAP Health Informatics and Neonatal Pediatrics Dalhousie University Halifax, Nova Scotia CANADA
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More informationQuality Scorecard overall heart attack care overall heart failure overall pneumonia care overall surgical infection rate patient safety survival
Quality Scorecard s are required to report quality statistics to the s for Medicare and Medicaid Services (CMS) and the Department of Health (DOH). This information is made available at www.hospitalcompare.hhs.gov
More informationTalking About Brain Death
Talking About Brain Death Tia Powell, MD Director, Montefiore-Einstein Center for Bioethics December 9, 2010 Overview Nature of the Problem Brief History of Brain Death Definition Standards for Testing
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationProtective Effects of Rheumatoid Arthritis in Septic ICU Patients
Innovations in Engineering Protective Effects of Rheumatoid Arthritis in Septic ICU Patients Mallory Sheth, Abdullah Chahin, Roger Mark, Natasha Markuzon The 2 nd International Workshop on Big Data in
More informationGeorgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:
Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR: CLINICAL UNIT: ASSIGNMENT DATES: PATIENT (last initial):
More informationAcutely ill patients in hospital
Acutely ill patients in hospital Recognition of and response to acute illness in adults in hospital Issued: July 2007 NICE clinical guideline 50 guidance.nice.org.uk/cg50 NICE 2007 Contents Introduction...
More informationToolkit: General Practice management of Sepsis
Toolkit: General Practice management of Sepsis This clinical toolkit has been developed in partnership with the Royal College of General Practitioners. It is designed to provide operational solutions to
More informationHealth risk assessment: a standardized framework
Health risk assessment: a standardized framework February 1, 2011 Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention Leading causes of death in the U.S. The 5 leading causes
More informationClinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
More informationUNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION
UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION NUMBER: P 1.01 Page 1 of 1 PATIENT SAFETY SYSTEM/PSS:
More informationTHE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
More informationMichelle Pinelle RN, BSN, CCRN & Jamie Roney RN, BSN, CCRN Texas Tech University Health Sciences Center, Lubbock, Texas
Michelle Pinelle RN, BSN, CCRN & Jamie Roney RN, BSN, CCRN Texas Tech University Health Sciences Center, Lubbock, Texas AGREE II Tool Evaluation of Sepsis Guidelines 1. The learner will be able to discuss
More informationThe Value of the Laboratory. Suzanne Carasso, MBA, MT (ASCP) Director, Business Solutions Consulting
The Value of the Laboratory Invest Outsource Suzanne Carasso, MBA, MT (ASCP) Director, Business Solutions Consulting Learning Objectives 1 discuss the state of 2 healthcare in the U.S. understand trends
More informationApplication of Engineering Principles to Patient Flow & Healthcare Delivery
Application of Engineering Principles to Patient Flow & Healthcare Delivery Jeanne M Huddleston, MD, MS Medical Director, Health Care Systems Engineering Mayo Clinic 2013 MFMER slide-1 2013 MFMER slide-2
More informationEHR Surveillance for Seasonal and Pandemic Influenza in Primary Care Settings
EHR Surveillance for Seasonal and Pandemic Influenza in Primary Care Settings Jonathan L. Temte, MD/PhD Chuck Illingworth University of Wisconsin School of Medicine and Public Health Department of Family
More informationMANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING
More informationElevated Serum Lactate Dehydrogenase Values in Children with Multiorgan Involvements and Severe Febrile Illness
Iranian Journal of Pediatrics Society Volume 1, Number 1, 2007: 31-35 Original Article Elevated Serum Lactate Dehydrogenase Values in Children with Multiorgan Involvements and Severe Febrile Illness Farah
More informationHealthcare Informatics and Clinical Decision Support. Deborah DiSanzo CEO Healthcare Informatics, Philips Healthcare
Healthcare Informatics and Clinical Decision Support Deborah DiSanzo CEO Healthcare Informatics, Philips Healthcare Leading the way Providing breakthroughs for more than a century * 1988 Technology was
More informationDIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs
DIABETES CARE What happens if you follow the Alphabet Strategy? As patients reach their targets, the chances of developing serious complications of diabetes will be reduced! 1 Stroke Eye disease Heart
More informationThe FDA s Mini- Sen*nel Program and the Learning Health System
info@mini- sen*nel.org 1 The FDA s Mini- Sen*nel Program and the Learning Health System Richard PlaB, MD, MS Harvard Pilgrim Health Care Ins*tute Harvard Medical School October 1, 2014 Vision We seek the
More informationCardio-Pulmonary Resuscitation (CPR): A Decision Aid For. KGH Patients And Their Families
Cardio-Pulmonary Resuscitation (CPR): A Decision Aid For KGH Patients And Their Families The goal of this pamphlet is to provide information about cardiopulmonary resuscitation (CPR) so you can be adequately
More informationEnvironmental Health Science. Brian S. Schwartz, MD, MS
Environmental Health Science Data Streams Health Data Brian S. Schwartz, MD, MS January 10, 2013 When is a data stream not a data stream? When it is health data. EHR data = PHI of health system Data stream
More informationPREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto
PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized
More informationSUPPLEMENTARY MATERIALS. Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial
1 SUPPLEMENTARY MATERIALS Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial Professor Ka Sing Lawrence Wong on behalf of The Executive Steering Committee and the ROCKET
More informationDVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
More informationSolution Title: Predicting Care Using Informatics/MEWS (Modified Early Warning System)
Organization: Peninsula Regional Medical Center Solution Title: Predicting Care Using Informatics/MEWS (Modified Early Warning System) Program/Project Description, including Goals: Problem: As stated in
More informationU.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
More informationPatterns of abnormal LFTs and their differential diagnosis
Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function
More informationRecommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
More informationService delivery interventions
Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P
More informationImpact of Critical Care Nursing on 30-day Mortality of Mechanically Ventilated Older Adults
Impact of Critical Care Nursing on 30-day Mortality of Mechanically Ventilated Older Adults Deena M. Kelly PhD RN Post-doctoral Fellow Department of Critical Care University of Pittsburgh School of Medicine
More informationSeverity scores in ICU
Severity scores in ICU DM seminar Dr.Vamsi Krishna Mootha Dept of Pulmonary medicine, PGIMER Introduction Severity of illness scoring systems are developed to evaluate delivery of care and provide prediction
More informationTransmission of HCV in the United States (CDC estimate)
Transmission of HCV in the United States (CDC estimate) Past and Future US Incidence and Prevalence of HCV Infection Decline among IDUs Overall incidence Overall prevalence Infected 20+ years Armstrong
More informationImplementation Guide
HAWAII HEALTH INFORMATION CORPORATION HAWAII S SOURCE FOR HEALTHCARE Implementation Guide ASCII HL7 Specifications for Laboratory Observation Reporting Technical Specifications and Transmittal Instructions
More informationThings You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
More informationSepsis Awareness Month
Aon Kenya Insurance Brokers Ltd Aon Hewitt Healthcare Division Sepsis Awareness Month Issue 11 September 2015 In this Issue 2 Getting to understand Sepsis 3 Stages in Sepsis Advancement 4 Diagnosis & Treatment
More informationSevere sepsis affects more than 20,000 children
ORIGINAL RESEARCH CONTRIBUTION The Utility of Early Lactate Testing in Undifferentiated Pediatric Systemic Inflammatory Response Syndrome Halden F. Scott, MD, Aaron J. Donoghue, MD, MSCE, David F. Gaieski,
More informationEarly Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi
Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi What is EWS? After qualifying, junior doctors are expected to distinguish between the moderately sick patients who can be managed in the
More informationDiabetic Emergencies. David Hill, D.O.
Diabetic Emergencies David Hill, D.O. Class Outline Diabetic emergency/glucometer training Identify the different signs of insulin shock Diabetic coma, and HHNK Participants will understand the treatment
More informationAlcoholic Hepatitis (Teacher s Guide)
Thomas Ormiston, M.D. Updated 5/5/15 2007-2015, SCVMC Alcoholic Hepatitis (Teacher s Guide) (30 minutes) I. Objectives Recognize the signs and symptoms of alcoholic hepatitis Understand the treatment options
More informationDIABETES. Eyes, Heart, Nerves, Feet, and Kidneys. www.kidney.org
DIABETES Eyes, Heart, Nerves, Feet, and Kidneys www.kidney.org About the Information in this Booklet Did you know that the National Kidney Foundation (NKF) offers guidelines and commentaries that help
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
More informationMedical Certificate of Cause of Death. Notes for Doctors
Medical Certificate of Cause of Death Notes for Doctors THE MEDICAL CERTIFICATE OF CAUSE OF DEATH 1. Introduction...1 2. Your duties as a medical practitioner...1 3. Personal details of deceased...3 4.
More informationMEDICARE RISK ADJUSTMENT A PROSPECTIVE APPROACH TO RISK ADJUSTMENT AND ACCURATE DOCUMENTATION AND CODING
MEDICARE RISK ADJUSTMENT A PROSPECTIVE APPROACH TO RISK ADJUSTMENT AND ACCURATE DOCUMENTATION AND CODING WHAT IS RISK ADJUSTMENT? Risk Adjustment ensures that accurate payments are made to Medicare Advantage
More informationValue-Based Purchasing Program Overview. Maida Soghikian, MD Grand Rounds Scripps Green Hospital November 28, 2012
Value-Based Purchasing Program Overview Maida Soghikian, MD Grand Rounds Scripps Green Hospital November 28, 2012 Presentation Overview Background and Introduction Inpatient Quality Reporting Program Value-Based
More informationAppendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
More informationValue of Modified Early Warning Score Among Critically Ill Patients
Med. J. Cairo Univ., Vol. 78, No. 1, December: 1-7, 2010 www.medicaljournalofcairouniversity.com Value of Modified Early Warning Score Among Critically Ill Patients ASHRAF HUSSEIN ABD AL MOHSEN, M.D. and
More informationBCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )
BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT ) Protocol Code Tumour Group Contact Physician UGIPNSUNI Gastrointestinal Dr. Hagen
More informationHEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: DIAGNOSIS OF SLEEP APNEA IN ADULTS DATE: 5/9/2013 HERC COVERAGE GUIDANCE
HEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: DIAGNOSIS OF SLEEP APNEA IN ADULTS DATE: 5/9/2013 HERC COVERAGE GUIDANCE The following diagnostic tests for Obstructive Sleep Apnea (OSA) should
More information嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
More informationAtrial Fibrillation in the ICU: Attempting to defend 4 controversial statements
Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary
More informationDiabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes
Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes Nursing home patients with diabetes treated with insulin and certain oral diabetes medications (i.e. sulfonylureas and glitinides) are
More informationHepatitis Update. HCV Cure As A Paradigm for Convergence of Interests. Evidence Based Nuts and Bolts For the Family Doc 11/5/2014
Evidence Based Nuts and Bolts For the Family Doc Hepatitis Update William Carey MD MACG, FAASLD Oct 25, 2014 HCV Cure As A Paradigm for Convergence of Interests Hepatitis C Cure 1 Get Ready Get SET Go
More informationA National Early Warning Score for the NHS
A National Early Warning Score for the NHS Professor Gary B Smith FRCA FRCP Centre of Postgraduate Medical Research & Education, School of Health and Social Care, Bournemouth University - from local data
More informationJames F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
More informationMeasures of Prognosis. Sukon Kanchanaraksa, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationDraft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases
SIXTY-SIXTH WORLD HEALTH ASSEMBLY A66/8 Provisional agenda item 13.1 15 March 2013 Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases
More information